Otonomy, Inc. (OTIC) News
Filter OTIC News Items
OTIC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
OTIC News Highlights
- For OTIC, its 30 day story count is now at 2.
- Over the past 1 day, the trend for OTIC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest OTIC News From Around the Web
Below are the latest news stories about OTONOMY INC that investors may wish to consider to help them evaluate OTIC as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayWe're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuedayWe're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning! |
Otonomy Adopts Dissolution & Liquidation Plans, Implements Workforce ReductionOtonomy Inc's (NASDAQ: OTIC) board of directors has approved and adopted a Plan of Liquidation and Dissolution that would include the distribution of remaining cash to stockholders following an orderly wind-down of the company's operations, including the proceeds from the sale of any pipeline assets. As previously reported, Otonomy initiated an evaluation of strategic options. The company is currently discussing the potential sale of its pipeline assets. Related: At Higher Doses, Otonomy's OTO-4 |
Otonomy Provides Corporate UpdateSAN DIEGO, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC) today announced that the company’s board of directors, after considering strategic options, has approved and adopted a Plan of Liquidation and Dissolution (“Plan of Dissolution”) that would include the distribution of remaining cash to stockholders following an orderly wind down of the company’s operations, including the proceeds from the sale of any pipeline assets. To reduce cost, Otonomy has implemented a reduction in w |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday! |
5 Investors Betting Big on Otonomy (OTIC) StockOTIC stock has flown higher in recent days, driven by a promotion from Twitter influencer Zack Morris. |
What Is Going on With Asia Broadband (AABB) Stock Today?Asia Broadband (AABB) stock is gaining on Tuesday as investors react to news of it reaching a major gold and silver ore milestone! |
Why Is Otonomy (OTIC) Stock Up 97% Today?Otonomy (OTIC) stock is on the move Tuesday with heavy trading despite a lack of news from the biopharmaceutical company. |
Otonomy Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateEvaluation of strategic options to realize value from pipeline is ongoingSAN DIEGO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today reported financial results for the quarter ended September 30, 2022 and provided an update on its product pipeline and corporate activities. Otonomy Program and Corporate Activity Updates In August 2022, Otonomy announced that OTO-313 demonstrat |
Otonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing LossHigher dose cohorts for OTO-413 demonstrated no clinically meaningful improvement for patients from baselineLack of activity compared to 0.3 mg dose evaluated in prior studies may be due to a complex dose-response relationship that has been observed with neurotrophinsOtonomy intends to explore strategic options to advance and realize value from its pipeline including both OTO-413 and OTO-825 SAN DIEGO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company de |